Gene · 252995
Papers4,118
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,118
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Postmenopausal sarcopenia and Alzheimer's disease: The interplay of mitochondria, insulin resistance, and myokines. | Neurosci Biobehav Rev | 2026 | 41325816 | PubTator, text mining | PubMed |
| The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline. | Ageing Res Rev | 2026 | 41275975 | PubTator, text mining | PubMed |
| Irisin-mediated hepatic autophagy remodels nutritional metabolism to prevent cognitive dysfunction. | Ageing Res Rev | 2026 | 41205629 | PubTator, text mining | PubMed |
| Muscular and plasma markers for early identification of frailty and sarcopenia states in people with HIV. | AIDS | 2026 | 41055966 | PubTator, text mining | PubMed |
| Phase-dependent changes in serum kisspeptin and irisin levels across the menstrual cycle in healthy women. | J Endocrinol Invest | 2026 | 41042501 | PubTator, text mining | PubMed |
| Assessment of Exercise-Stimulated Irisin in Kidney Disease: A Systematic Review. | Endocr Metab Immune Disord Drug Targets | 2026 | 40990273 | PubTator, text mining | PubMed |
| A Cross-sectional Analysis of Serum Irisin Levels in Individuals with Thyroid Dysfunction Compared to the Control Population. | Ann Afr Med | 2026 | 40977446 | PubTator, text mining | PubMed |
| Dapagliflozin attenuates lipotoxic tenocyte injury via PPARα activation and irisin-driven antioxidant pathways. | Connect Tissue Res | 2026 | 40959984 | PubTator, text mining | PubMed |
| Stable Cytokine Network during Hypoxia and Exercise in Patients with Fontan Circulation. | Int J Cardiol | 2026 | 40921273 | PubTator, text mining | PubMed |
| Circulating adipokines in girls with central precocious puberty: A systematic review and meta-analysis. | Pediatr Res | 2026 | 40355541 | PubTator, text mining | PubMed |
| Irisin alleviates hepatic steatosis by activating the autophagic SIRT3 pathway. | Chin Med J (Engl) | 2026 | 39965865 | PubTator, text mining | PubMed |
| Aerobic exercise-induced myokine irisin release: A novel strategy to promote neuroprotection and improve cognitive function. | Neural Regen Res | 2026 | 39665814 | PubTator, text mining | PubMed |
| CRISPR-based Transcriptional Regulation: Technologies, Applications, and Future Directions. | DNA (Basel) | 2025 | 41877893 | PubTator, text mining | PubMed |
| Unraveling the metabolic pathways between atherosclerosis and sarcopenia. | Front Endocrinol (Lausanne) | 2025 | 41726101 | PubTator, text mining | PubMed |
| Acute and chronic effects of high-intensity interval training on selected exerkine secretion in health, disease, and aging: a systematic review. | Front Physiol | 2025 | 41659923 | PubTator, text mining | PubMed |
| Association of circulating muscle-derived myokines irisin and myostatin with COVID-19 severity. | Front Endocrinol (Lausanne) | 2025 | 41625244 | PubTator, text mining | PubMed |
| Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes. | Pediatr Diabetes | 2025 | 41585414 | PubTator, text mining | PubMed |
| Comparative psychological well-being evaluation among CKD patients on conservative therapy, dialysis, or kidney transplantation: a cross-sectional study. | Front Psychol | 2025 | 41567468 | PubTator, text mining | PubMed |
| The myokine irisin: effects on the brain and therapeutic potential in the treatment of depression and neurodegenerative diseases. | Biomed Khim | 2025 | 41556070 | PubTator, text mining | PubMed |
| Kynurenine Pathway Metabolites as Mediators of Exercise-Induced Mood Enhancement, Fatigue Resistance, and Neuroprotection. | Int J Mol Sci | 2025 | 41516008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/252995/papers?page=14